Relacorilant and Nab-Paclitaxel in Patients With Platinum-Resistant Ovarian Cancer (ROSELLA): An Open-label, Randomized, Controlled, Phase 3 Trial
Year: 2025
Type: article
Authors: Alexander B. Olawaiye, Laurence Gladieff, David M. O’Malley, Jae-Weon Kim, Gabriel Garbaos, Vanda Salutari, Lucy Gilbert, Linda Mileshkin, Alix Devaux, Elizabeth Hopp, Yong Jae Lee, Ana Oaknin, Mariana Scaranti, Byoung-Gie Kim, Nicoletta Colombo, Michael E. McCollum, Connie Diakos, Andrew Clamp, Aliza L. Leiser, Boglárka Balazs, Bradley J. Monk, Giuseppa Scandurra, Emily McClung, Emilie Kaczmarek, Brian Slomovitz, Helena De La Creva, Aknar Freire do Carvalho Calabrich, Chiara Cassani, Benoit You, Toon Van Gorp, Cristina Churruca, Giuseppe Caruso, Shibani Nicum, Andrea Bagameri, Grazia Artioli, Lubomir Bodnar, Sokbom Kang, Ignace Vergote, Amanda Kesner-Hays, Hristina I. Pashova, Sachin G. Pai, Iulia Cristina Tudor, Adrian M. Jubb, Domenica Lorusso
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414880314
FWCI:
Cites:
Cited by:
Related to: